(Q38474339)

English

Risk factors for infection and treatment outcome of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae bacteremia in patients with hematologic malignancy

scientific article published on 10 May 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Risk factors for infection and treatment outcome of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae bacteremia in patients with hematologic malignancy (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Klebsiella pneumoniae

0 references

Escherichia coli

1 reference

based on heuristic

inferred from title

4

0 references

3

0 references

Doo Ryeon Chung

2

object named as

Doo Ryeon Chung

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Korean Network for Study of Infectious Diseases

6

object named as

Korean Network for Study of Infectious Diseases

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

author name string

Cheol-In Kang

1

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Jae-Hoon Song

5

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

publication date

10 May 2011

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Annals of Hematology

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

91

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

115-121

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Risk factors for, and clinical relevance of, faecal extended-spectrum β-lactamase producing Escherichia coli (ESBL-EC) carriage in neutropenic patients with haematological malignancies.

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1247-7

21 January 2018

Nosocomial bacteremia caused by antibiotic-resistant gram-negative bacteria in critically ill patients: clinical outcome and length of hospitalization.

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1247-7

21 January 2018

Cefepime-resistant Gram-negative bacteremia in febrile neutropenic patients with hematological malignancies

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1247-7

21 January 2018

Bacteraemia due to extended-spectrum beta-lactamase-producing Escherichia coli (ESBL-EC) in cancer patients: clinical features, risk factors, molecular epidemiology and outcome.

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1247-7

21 January 2018

Bacteraemia due to multidrug-resistant Gram-negative bacilli in cancer patients: risk factors, antibiotic therapy and outcomes.

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1247-7

21 January 2018

Bloodstream infections caused by Enterobacter species: predictors of 30-day mortality rate and impact of broad-spectrum cephalosporin resistance on outcome

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1247-7

21 January 2018

Hematologic malignancy as a risk factor for bacteremic skin and soft tissue infection caused by gram-negative bacilli

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1247-7

21 January 2018

Risk factors and pathogenic significance of severe sepsis and septic shock in 2286 patients with gram-negative bacteremia

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1247-7

21 January 2018

Risk factors and treatment outcomes of community-onset bacteraemia caused by extended-spectrum beta-lactamase-producing Escherichia coli

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1247-7

21 January 2018

Bloodstream infections by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in children: epidemiology and clinical outcome

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1247-7

21 January 2018

Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1247-7

21 January 2018

Mortality and delay in effective therapy associated with extended-spectrum beta-lactamase production in Enterobacteriaceae bacteraemia: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1247-7

21 January 2018

Bloodstream infections and clinical significance of healthcare-associated bacteremia: a multicenter surveillance study in Korean hospitals

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1247-7

21 January 2018

Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1247-7

21 January 2018

Bloodstream infections caused by extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae: risk factors, molecular epidemiology, and clinical outcome

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1247-7

21 January 2018

Identifiers

10.1007/S00277-011-1247-7

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38474339&oldid=1784183104"